The delay to thrombolysis: An analysis of hospital and patient characteristics

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 4, 1998, Pages 475-480

  Brophy, James M ^a   Diodati, Jean G ^b   Bogaty, Peter ^c   Théroux, Pierre ^d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; CANADA; CLINICAL PRACTICE; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONSULTATION; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; REGISTER; RISK; TIME; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0032562193     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GISSI Investigators. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;8478:397-402.
2. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,817 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;8607:349-60.
3. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [published erratum appears in Lancet 1994;343:742]. Lancet 1994;343:311-22.
5. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
6. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolytics for acute myocardial infarction. Lancet 1996;347:1203-7.
7. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-14.
8. GISSI - Avoidable Delay Study Group. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. Arch Intern Med 1995;155:1481-8.
9. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-I investigators. J Am Coll Cardiol 1996;27:1646-55.
10. Cox JL, Lee E, Langer A, Armstrong PW, Naylor CD, for the Canadian GUSTO Investigators. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Can Med Assoc J 1997;156:497-505.
11. Cairns J, Armstrong P, Belenkie I, Hirsh J, Johnstone D, Knudtson M, et al. Canadian Consensus Conference on Coronary Thrombolysis - 1994 update. Can J Cardiol 1994;10:517-29.
12. Letovsky E, Allen T. Initiating thrombolytic therapy for acute myocardial infarction: Whose job is it anyway? [editorial]. Can Med Assoc J 1996;154:509-11.
13. Diamond GA, Forrester JS. Clinical trials and statistical verdicts: probable grounds for appeal. Ann Intern Med 1983;98:385-94.
14. Jollis JG, DeLong ER, Peterson ED, Muhlbaier LH, Fortin DF, Califf RM, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996;335:1880-7.
15. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med J 1994;331:1136-42.
16. Brophy JM, Joseph L. Placing trials in context using bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA 1995;273:871-5.
17. Hannan EL, Kilburn H, Bernard H, O'Donnell JF, Lukacik G, Shields EP. Coronary artery bypass surgery: the relationship between in-hospital mortality rate and surgical volume after controlling for clinical risk factors. Med Care 1991;29:1094-107.
18. Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1995;274:1137-42.
19. Burnett RE, Blumenthal JA, Mark DB, Leimberger JD, Califf RM. Distinguishing between early and late responders to symptoms of acute myocardial infarction. Am J Cardiol 1995;75:1019-22.
20. Wielgosz AT, Nolan RP. Understanding delay in response to symptoms of acute myocardial infarction. A compelling agenda. Circulation 1991;84:2193-5.